U.S. RESEARCH ROUNDUP-Cintas, Nasdaq, Talen Energy

Reuters09-26 14:51

Sept 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cintas, Nasdaq and Talen Energy, on Thursday.

HIGHLIGHTS

* Cintas Corp : JP Morgan raises target price to $228 from $212.5

* Nasdaq Inc : TD Cowen initiates coverage with hold rating; PT $83

* Talen Energy Corp : RBC initiates coverage with outperform rating; PT $233

Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* Affirm Holdings Inc : Jefferies raises target price to $39 from $32

* Bristol-Myers Squibb Co : Jefferies raises target price to $53 from $51

* CBOE Global Markets Inc : TD Cowen initiates coverage with hold rating; PT $205

* Chesapeake Energy Corp : CFRA initiates coverage with sell rating; PT $71

* Cintas Corp : JP Morgan raises target price to $228 from $212.5

* Cintas Corp : RBC raises target price to $215 from $181

* CME Group Inc : TD Cowen initiates coverage with hold rating; target price $221

* Dorian Lpg Ltd : Jefferies cuts target price to $42 from $50

* Draftkings Inc : JP Morgan raises target price to $54 from $48

* Emerson : Oppenheimer raises target price to $125 from $120

* Intercontinental Exchange Inc : TD Cowen initiates coverage with buy rating; PT $182

* Keurig DR Pepper Inc : TD Cowen raises target price to $40 from $35

* Kymera Therapeutics Inc : Piper Sandler raises target price to $60 from $56

* Legend Biotech Corp : JP Morgan raises target price to $80 from $79

* Meta : Baird raises target price to $605 from $530

* Meta : JP Morgan raises target price to $640 from $610

* Nasdaq Inc : TD Cowen initiates coverage with hold rating; PT $83

* Palantir Technologies Inc : Wedbush raises target price to $45 from $38

* Pennant Group Inc : Stephens raises target price to $40 from $32

* Talen Energy Corp : RBC initiates coverage with outperform rating; PT $233

* Tradeweb Markets Inc : TD Cowen initiates coverage with buy rating; PT $139

* Viridian Therapeutics Inc : BTIG raises target price to $61 from $56

* Worthington Enterprises Inc : Canaccord Genuity cuts PT to $46 from $52

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment